Some much-needed optimism has made its way to the Street. The expectation that a vaccine against COVID-19 will be “widely distributed” by the middle of 2021 prompted an estimate revision from Goldman Sachs. Giving its projections for 2021 U.S. GDP a lift, the figure moves up from 5.6% to 6.2%. “We now expect that at least one vaccine will be approved by the end of 2020 and will be widely distributed by the end of 2021 Q2,” Goldman Sachs’ chief economist Jan Hatzius wrote in a note to clients. As for unemployment rates, the firm also anticipates an improvement, …read more
Source:: Yahoo Finance
